Printer Friendly
The Free Library
14,787,278 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Amphion Innovations plc Placing Raises GBP 1,032,800.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Amphion Innovations plc (LSE LSE - Language Sensitive Editor :AMP; "Amphion"), a leading developer and operator of companies in the life sciences and medical technology sectors, today announces that it has successfully raised GBP GBP

In currencies, this is the abbreviation for the British Pound.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 1,032,800 (before expenses).

Under the terms of the placing, the Company has issued 3,972,307 new ordinary shares at 26 pence per share (the "Placing Shares").

The net proceeds Net Proceeds

The amount received after all costs are deducted from the sale of a piece of property or security.

Notes:
In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions).
 from the placing will be used to invest in new and identified opportunities.

Application will be made for the Placing Shares to be admitted to trading on AIM. It is expected that admission will occur at 8.00 a.m. on 15 August. The Placing Shares will rank pari passu [Latin, By an equal progress; equably; ratably; without preference.] Used especially to describe creditors who, in marshalling assets, are entitled to receive out of the same fund without any precedence over each other.


PARI PASSU. By the same gradation.
 in all respects with the existing Ordinary Shares which are currently traded on AIM. Following admission the total number of shares in issue will be 97,611,762.

"We have made tremendous progress this year, and this further financing will help us to continue the successful development of our partner companies," said Richard C. Morgan, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Amphion. "These companies are at the leading edge of innovation as they address important market needs in life sciences and information technology."

About Amphion Innovations plc

Amphion Innovations plc is listed on the AIM Exchange in London under the symbol AMP. Amphion's business is the formation, financing, management and development of life sciences and technology companies, working in partnership with corporations, governments, universities and entrepreneurs seeking to commercialize their intellectual property.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 9, 2006
Words:241
Previous Article:BPS Launches Next Generation Operational Risk Management Platform for Financial Institutions - New Capabilities Increase Control with Customizable...
Next Article:Fitch Ratings Affirms COMM 2004-LNB2.
Topics:



Related Articles
Amphion Innovations Announces Further Investment.
Amphion Innovations plc Preliminary Results Show 24% Increase In Net Asset Value Per Share Over Four Months Since IPO; Strong Progress with Partner...
Amphion Innovations plc Partner Company AXCESS International Completes $2.3M Funding.
Amphion Innovations plc Annual General Meeting Trading Update.
Amphion Innovations plc Partner Company Supertron Raises $3.5 Million in Series C Financing.
FireStar Software, Inc. Raises Additional $2 Million.
Amphion Innovations plc Interim Results Show 21 Percent Gain in Fair Value of Investments.
Amphion Innovations plc Acquires 35% Stake in Manchester Molecular Diagnostic Spin-out Company.
Amphion Innovations plc Announces Fundraising.
Amphion Innovations Partner Company Motif Biosciences Closes $1m Financing.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles